Abstract:Background:The majority of patients with colorectal cancer (CRC) have increased levels of soluble cancer-associated biomarkers at diagnosis of primary disease.Subjects with clean colorectum at colonoscopy may however, also have increased levels of such biomarkers.The aim of the present study was to evaluate a possible association between increased levels of soluble TIMP-1, CEA, CA19-9 and YKL-40 in subjects offered colorectal endoscopy without findings of neoplastic bowel lesions and subsequent long-term risk of developing a primary malignant disease.Methods: During 2004/05 4,509 subjects were included in a multicenter study with collection of blood samples before sigmoido-and/or colonoscopy due to symptoms of CRC.The aim was to evaluate a possible relation between certain biomarkers and subsequent findings at endoscopy.A subgroup of 1,025 subjects had findings of diverticula and was chosen as research group, because the median age was similar to the subjects diagnosed with colorectal neoplasia.The levels of TIMP-1, CEA and CA19-9 were determined in EDTA plasma at an automatic analysis platform "Architect®" at Abbotts Center of Excellence, Amsterdam and YKL-40 was determined on a validated commercially available ELISA platform (Quidell, USA) at Herlev Hospital.With cut-point 12.31.2012 the subjects, who have developed a primary malignant disease, except skin cancer, were identified and a relation between the biomarker levels at endoscopy and long-term risk of developing malignancy was calculated.On the basis of calculated normal levels, the relation with the biomarkers was separated into three groups: 0 = none of the four increased; 1 = one of the four increased; 2 = two or more of the four increased.In addition, the time from endoscopy to development of malignancy within the first five years was included; the model also includes an analysis of competing risk of dead before development of malignancy.Results: In total, 152 of the 1,025 subjects with diverticula developed a primary malignant disease within the observation period.Univariate analyses of the biomarker levels in the three predefined groups showed that TIMP-1 (p=0.0004),CEA (p=0.009) and CA19-9 (p=0.028) were significantly associated with development of malignancy.In a subsequent multivariate analysis including the three biomarkers showed that increased levels were associated with development of subsequent malignancy (p=0.0014).The cumulated risk of developing a primary malignant disease within the first five years was: group 0: 0.075 (0.055-0.099); group 1: 0.088 (0.059-0.126); group 2: 0.167 (0.120-0.221).Conclusion: Increased levels of the soluble biomarkers plasma TIMP-1, CEA and CA19-9 at endoscopy with findings of diverticula are associated with subsequent risk of developing a primary malignant disease.

The Association Between Chinese Patients' Elevated Omentin-1 Levels, Their Clinicopathological Features, and the Risk of Colorectal Cancer.

Association Between the Omentin-1 Gene Rs2274907 A>T Polymorphism and Colorectal Cancer in the Chinese Han Population: a Case-Control Study

Autocrine Action of Adipokine Omentin-1 in the SW480 Colon Cancer Cell Line.

Association between serum omentin-1 and mucosal disease activity in patients with ulcerative colitis

Expression and its clinical significance of plasma omentin-1 in patients with coronary heart disease and central obesity

Association of Circulating Omentin-1 with Osteoporosis in a Chinese Type 2 Diabetic Population

Effect of Omentin-1 on Cancer Stem Cell Surface Markers and Tumour-Suppressive Mirna Expression in a High-Glucose Environment Associated with Colorectal Cancer.

Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls

Association of Plasma Total and High-Molecular-weight Adiponectin with Risk of Colorectal Cancer: an Observational Study in Chinese Male

Association Between Omentin and Echo Parameters in Patients with Chronic Heart Failure.

Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults

Serum Leptin, Adiponectin and Endometrial Cancer Risk in Chinese Women

Association between serum omentin-1 level and childhood non-alcoholic fatty liver disease

Circulating And Adipose Tissue Mrna Levels Of Zinc-Alpha 2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, And Tumor Necrosis Factor-Alpha In Colorectal Cancer Patients With Or Without Obesity

Serum Omentin Level and Related Factors in Obese and Type 2 Diabetic Patients

Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis

Omentin-1 is Associated with Carotid Atherosclerosis in Patients with Metabolic Syndrome

Serum Omentin-1 Levels in Overweight and Obese People

872 Mir-650: A Potential Prognostic Biomarker and Therapeutic Target in Non-Metastasis Colorectal Carcinoma

The study on plasma adiponectin levels and risk of colorectal cancer

[Expression of Omentin in Adipose Tissues in Obese and Type 2 Diabetic Patients].